CN1356128A - Chinese medicine for treating rheumatic and rheumatoid diseases - Google Patents

Chinese medicine for treating rheumatic and rheumatoid diseases Download PDF

Info

Publication number
CN1356128A
CN1356128A CN01131742A CN01131742A CN1356128A CN 1356128 A CN1356128 A CN 1356128A CN 01131742 A CN01131742 A CN 01131742A CN 01131742 A CN01131742 A CN 01131742A CN 1356128 A CN1356128 A CN 1356128A
Authority
CN
China
Prior art keywords
grams
radix
caulis
preparation
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN01131742A
Other languages
Chinese (zh)
Other versions
CN1180808C (en
Inventor
吴大展
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011317426A priority Critical patent/CN1180808C/en
Publication of CN1356128A publication Critical patent/CN1356128A/en
Application granted granted Critical
Publication of CN1180808C publication Critical patent/CN1180808C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine for treating rheumatic and rheumatoid diseases is prepared from 17 Chinese-medicinal materials including futokadsura stem, clematis root, pubescent angelica root, Chinese gall root, etc. Its advantages include high curative rate (more than 90%), no toxic by-effect, no and recurrence.

Description

A kind of treatment rheumatism, rheumatoid pure Chinese medicinal preparation
Technical field
The invention belongs to treatment rheumatism, rheumatoid medicine, specifically a kind of rheumatism, rheumatoid pure Chinese medicinal preparation of being used for the treatment of.
Background technology
Rheumatism is one of commonly encountered diseases frequently-occurring disease of serious harm people's health.This sick method of treatment has two kinds at present, a kind of is doctor trained in Western medicine, think that this disease is because human body Hemolytic streptococcus or viral infection cause, the medicine of anti-inflammatory analgesic is adopted in treatment usually, as salicylic acid preparation, ibuprofen, piroxicam and adrenocortical steroid and immunosuppressant etc., these medicines mostly can only relief of symptoms, can not effect a radical cure, and toxic side effect is taken for a long time, and patient's the heart, liver, kidney, gastrointestinal tract and reproductive system all had tangible detrimental effect.Another kind of is treatment by Chinese herbs, as the patent No. is 97114453, " a kind of treatment rheumatism, rheumatoid Chinese medicine preparation and preparation method thereof " disclosed preparation by name, its component has Formica fusca, Rhizoma Curculiginis, Semen Sinapis Albae (parched), Zaocys, Rhizoma Gastrodiae, Herba Ephedrae, Cortex Cinnamomi, Cornu Cervi Degelatinatum, stir-baked SQUAMA MANITIS, Radix Angelicae Sinensis, Radix Notoginseng, Os Draconis, Rhizoma Zingiberis.And for example the patent No. is 97115872, " a kind of pure Chinese medicine capsule for the treatment of the rheumatism of class " disclosed Chinese medicine preparation by name, and its composition has Semen Strychni (processed), Semen daturae and Pyritum (calcined).The described patent No. is to contain the wild Squama Manis that watches for animals of national secondary in 97114453 the preparation, and use is restricted; The patent No. is to contain the bigger Semen Strychni of toxic side effect in 97115872 the preparation, general in dose few, and can not use for a long time, if dose is big, limbs vibration, paralysis can appear, anemia of pregnant woman, body void and taste weak person avoid clothes.
Summary of the invention
The present invention is for overcoming the deficiency of prior art, proposes a kind ofly to have no side effect, the treatment rheumatism of medication economy, rheumatoid pure Chinese medicinal preparation.
Chinese medicine preparation of the present invention by Caulis Sinomenii, Caulis Piperis Kadsurae, Qi Lingxian, Radix Zanthoxyli Spinifolii, Millettia Speciosa, Radix Angelicae Pubescentis, Galla Chinensis root, sting luxuriant Celastrus orbiculatus Thunb., Herba Equiseti Hiemalis, Radix Chaenomelis, Radix Rubiae, Fructus Xanthii, Radix Bupleuri, Caulis Polygoni Multiflori, the Radix Angelicae Dahuricae, Radix Puerariae and Rhizoma Acori Graminei and form, all with the crude drug preparation, every flavor medicine amount of getting is 3-5 to described medicine by weight.During use, mix by every flavor medicine 3-5 weight ratio, pulverize and be powder that can be oral, be made as capsule or pill, every day, consumption was no more than 100 grams, and each consumption is the 15-25 gram.
The technical scheme that the present invention deals with problems is to learn understanding and the Therapeutic Principle that rheumatism is fallen ill according to motherland's Chinese medicine, select expelling wind and removing dampness class, suppressing the hyperactive liver to relieve the wind syndrome class, blood circulation promoting and blood stasis dispelling class, removing dampness class, the Xin Wen cold class Chinese herbal medicine that dispels the wind for use, energy detumescence and promoting granulation collateral dredging, expelling wind and removing dampness, invigorating the liver and kidney, bone and muscle strengthening, cold type of pain is ended in sharp joint.Compared with prior art, do not have the taboo of " anti-fear ", human body is had no side effect, cure rate reaches more than 90%; The used medicine medicine of the present invention source is rich and easy to get, cheap, patient's medication economy.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Example formulations 1
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 25 grams, Radix Zanthoxyli Spinifolii 15 grams, Millettia Speciosa 17 grams, Radix Angelicae Pubescentis 16 grams, Galla Chinensis root 20 grams, luxuriant Celastrus orbiculatus Thunb. 25 grams of thorn, Herba Equiseti Hiemalis's 25 grams, Radix Chaenomelis 20 grams, Radix Rubiae 18 grams, Fructus Xanthii 15 grams, Radix Bupleuri 20 grams, Caulis Polygoni Multiflori 17 grams, the Radix Angelicae Dahuricae 16 grams, Radix Puerariae 20 grams and Rhizoma Acori Graminei 25 grams.
Example formulations 2
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 15 grams, Radix Zanthoxyli Spinifolii 18 grams, Millettia Speciosa 16 gram Radix Angelicae Pubescentiss 15 grams, Galla Chinensis root 15 grams, luxuriant Celastrus orbiculatus Thunb. 20 grams of thorn, Herba Equiseti Hiemalis's 20 grams, Radix Chaenomelis 15 grams, Radix Rubiae 20 grams, Fructus Xanthii 15 grams, Radix Bupleuri 15 grams, Caulis Polygoni Multiflori 15 grams, the Radix Angelicae Dahuricae 20 grams, Radix Puerariae 25 grams and Rhizoma Acori Graminei 20 grams.
Example formulations 3
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 20 grams, Radix Zanthoxyli Spinifolii 20 grams, Millettia Speciosa 15 grams, Radix Angelicae Pubescentis 20 grams, Galla Chinensis root 15 grams, luxuriant Celastrus orbiculatus Thunb. 25 grams of thorn, Herba Equiseti Hiemalis's 20 grams, Radix Chaenomelis 20 grams, Radix Rubiae 15 grams, Fructus Xanthii 16 grams, Radix Bupleuri 20 grams, Caulis Polygoni Multiflori 15 grams, the Radix Angelicae Dahuricae 25 grams, Radix Puerariae 20 grams and Rhizoma Acori Graminei 25 grams.
Example formulations 4
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 20 grams, Radix Zanthoxyli Spinifolii 15 grams, Millettia Speciosa 15 grams, Radix Angelicae Pubescentis 14 grams, Galla Chinensis root 12 grams, luxuriant Celastrus orbiculatus Thunb. 20 grams of thorn, Herba Equiseti Hiemalis's 25 grams, Radix Chaenomelis 15 grams, Radix Rubiae 13 grams, Fructus Xanthii 15 grams, Radix Bupleuri 15 grams, Caulis Polygoni Multiflori 20 grams, the Radix Angelicae Dahuricae 20 grams, Radix Puerariae 15 grams and Rhizoma Acori Graminei 15 grams.
Example formulations 5
Caulis Sinomenii 25 grams, Caulis Piperis Kadsurae 25 grams, Radix Clematidis 20 grams, Radix Zanthoxyli Spinifolii 20 grams, Millettia Speciosa 20 grams, Radix Angelicae Pubescentis, Galla Chinensis root 20 grams, luxuriant Celastrus orbiculatus Thunb. 15 grams of thorn, Herba Equiseti Hiemalis's 20 grams, Radix Chaenomelis 20 grams, Radix Rubiae 15 grams, Fructus Xanthii 20 grams, Radix Bupleuri 20 grams, Caulis Polygoni Multiflori 20 grams, the Radix Angelicae Dahuricae 18 grams, Radix Puerariae 20 grams and Rhizoma Acori Graminei 25 grams.
Chinese medicine title of the present invention comes from " national Chinese herbal medicine compilation " (the limitting domestic distribution) that the People's Health Publisher publishes in April, 1978.

Claims (1)

  1. Treat rheumatism, rheumatoid pure Chinese medicinal preparation for 1 one kinds, it is characterized in that said preparation by Caulis Sinomenii, Caulis Piperis Kadsurae, Radix Clematidis, Radix Zanthoxyli Spinifolii, Millettia Speciosa, Radix Angelicae Pubescentis, Galla Chinensis root, sting luxuriant Celastrus orbiculatus Thunb., Herba Equiseti Hiemalis, Radix Chaenomelis, Radix Rubiae, Fructus Xanthii, Radix Bupleuri, Caulis Polygoni Multiflori, the Radix Angelicae Dahuricae, Radix Puerariae and Rhizoma Acori Graminei and form, all with the crude drug preparation, every flavor medicine amount of getting is 3-5 to described medicine by weight.
CNB011317426A 2001-09-29 2001-09-29 Chinese medicine for treating rheumatic and rheumatoid diseases Expired - Fee Related CN1180808C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011317426A CN1180808C (en) 2001-09-29 2001-09-29 Chinese medicine for treating rheumatic and rheumatoid diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011317426A CN1180808C (en) 2001-09-29 2001-09-29 Chinese medicine for treating rheumatic and rheumatoid diseases

Publications (2)

Publication Number Publication Date
CN1356128A true CN1356128A (en) 2002-07-03
CN1180808C CN1180808C (en) 2004-12-22

Family

ID=4670824

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011317426A Expired - Fee Related CN1180808C (en) 2001-09-29 2001-09-29 Chinese medicine for treating rheumatic and rheumatoid diseases

Country Status (1)

Country Link
CN (1) CN1180808C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101474261B (en) * 2008-12-03 2011-06-15 赵志库 Chinese medicine for treating rheumatic osteonosus
CN103933408A (en) * 2014-05-15 2014-07-23 肖贻泰 Traditional Chinese medicinal decoction for treating acute gouty arthritis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101474261B (en) * 2008-12-03 2011-06-15 赵志库 Chinese medicine for treating rheumatic osteonosus
CN103933408A (en) * 2014-05-15 2014-07-23 肖贻泰 Traditional Chinese medicinal decoction for treating acute gouty arthritis

Also Published As

Publication number Publication date
CN1180808C (en) 2004-12-22

Similar Documents

Publication Publication Date Title
CN102178895B (en) Chinese medicine composition for treating orthopedic disorders and preparation method thereof
CN103356877A (en) Traditional Chinese medicine composition for treating orthopedic diseases
CN102100872A (en) Chinese medicine preparation for treating mastitis
CN102247497A (en) Chinese patent medicine for treating rheumatoid arthritis
CN102078527A (en) Traditional Chinese medicine formula for treating urinary calculus
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN100333738C (en) Chinese medicinal ointment for treating bone diseases
CN1180808C (en) Chinese medicine for treating rheumatic and rheumatoid diseases
CN101940656A (en) Medicament for treating hyperosteogeny
CN102145099A (en) Traditional Chinese medicine for treating infertility caused by liver stagnation
CN105362382A (en) Traditional Chinese medicine composition for treating recurrent oral ulcer and application thereof
CN104800443A (en) Bone setting agent with functions of tonifying kidney and regenerating bone marrow
CN1210005A (en) Medicine for necrosis of femoral head
CN1054052C (en) Comedo-elimination preparation
CN101554461B (en) Medicine for treating psoriasis and preparation method of capsule thereof
CN1235840A (en) Chinese medicine powder for curing rheumatoid and rheumatic diseases
CN102872293A (en) Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease
CN106421534A (en) Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof
CN1162163C (en) Chinese herbal medicinal liquor for curing rheumatic arthritis
CN1305508C (en) Pill for treating coronary heart disease
CN1840146A (en) Medicament for treating vitiligo
CN100341563C (en) Chinese medicinal capsule for treating metrorrhagia and metrostaxis
CN1190593A (en) Medicine for the treatment of rheumatism and arthritis
CN1557365A (en) Medicine
CN105412244A (en) Traditional Chinese medicine composition treating gynecological cervicitis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice

Addressee: Wu Dazhan

Document name: Notification of Termination of Patent Right

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041222

Termination date: 20100929